DENTSPLY SIRONA INC (XRAY)

US24906P1093 - Common Stock

18.52  -0.36 (-1.91%)

After market: 18.52 0 (0%)

Buy % Consensus

78

ChartMill assigns a Buy % Consensus number of 78% to XRAY. The Buy consensus is the weighted average rating of the current analysts ratings.

Analysts have set a mean price target forecast of 32.08. This target is 73.24% above the current price.
XRAY was analyzed by 21 analysts. The buy percentage consensus is at 78. So analysts seem to be have mildly positive about XRAY.
In the previous month the buy percentage consensus was at a similar level.
XRAY was analyzed by 21 analysts, which is quite many. So the average rating should be quite meaningful.

Price Target & Forecast

Price Low Median Mean High 18.5227.2732.6432.0837.80 - 47.25% 76.24% 73.24% 104.10%
Up and Down Grades
Date Firm Action Rating
2024-11-08 Barrington Research Maintains Outperform -> Outperform
2024-11-08 Baird Maintains Neutral -> Neutral
2024-11-07 Leerink Partners Downgrade Outperform -> Market Perform
2024-10-28 Needham Maintains Buy -> Buy
2024-10-08 Evercore ISI Group Maintains Outperform -> Outperform
2024-09-20 Barrington Research Maintains Outperform -> Outperform
2024-08-20 Needham Reiterate Buy -> Buy
2024-07-31 Needham Maintains Buy -> Buy
2024-07-22 Baird Maintains Neutral -> Neutral
2024-07-18 Stifel Maintains Hold -> Hold
2024-07-09 Evercore ISI Group Maintains Outperform -> Outperform
2024-07-08 Barrington Research Maintains Outperform -> Outperform
2024-06-25 Evercore ISI Group Maintains Outperform -> Outperform
2024-05-06 Goldman Sachs Maintains Neutral -> Neutral
2024-05-03 Barrington Research Maintains Outperform -> Outperform
2024-05-03 Needham Maintains Buy -> Buy
2024-05-03 Evercore ISI Group Maintains Outperform -> Outperform
2024-05-03 Baird Maintains Neutral -> Neutral
2024-05-03 Piper Sandler Reiterate Neutral -> Neutral
2024-04-18 Barrington Research Maintains Outperform -> Outperform
2024-03-01 Barrington Research Reiterate Outperform -> Outperform
2024-02-29 Needham Reiterate Buy -> Buy
2024-02-26 Leerink Partners Initiate Outperform
2024-01-12 Piper Sandler Maintains Neutral -> Neutral
2024-01-09 Needham Maintains Buy -> Buy
2023-11-16 Needham Initiate Buy
2023-11-13 Stifel Maintains Hold -> Hold
2023-11-10 William Blair Upgrade Market Perform -> Outperform
2023-11-07 Goldman Sachs Maintains Neutral -> Neutral
2023-11-03 Barrington Research Maintains Outperform -> Outperform